Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trialsJ L Perez-Gracia, N Penel, E Calvo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2019
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC studyA Le Cesne, P Marec-Berard, J-Y Blay, et al.
British Journal of Cancer|August 8, 2013
A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma GroupP A Cassier, A Lefranc, E Y Amela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2008
Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma GroupA Italiano, N Penel, Y-M Robin, et al.
ESMO Open|February 1, 2021
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomasM Brahmi, T Lesluyes, A Dufresne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survivalA Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survivalA Italiano, M Toulmonde, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2017
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapyK Fizazi, A Ulys, L Sengeløv, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2022
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 studyM Maio, P A Ascierto, L Manzyuk, et al.
Pageof 11